Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,147.60
(
0.55%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.74
(
2.48%
)
Bitcoin
74,549.03
(
-0.39%
)
News Focus
News Focus
Post# of 30493
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 2470

Monday, 04/11/2011 1:12:55 PM

Monday, April 11, 2011 1:12:55 PM

Post# of 30493
MRK inks branded-generics deal for emerging markets with India’s Sun Pharma:

http://finance.yahoo.com/news/Merck-Co-Inc-and-Sun-Pharma-bw-2289043827.html?x=0

Financial terms were not disclosed.

The Global Demographic Tailwind, which manifests itself via escalating sales of branded generics in emerging markets, has become the most important growth driver for the global pharmaceutical industry.

See #msg-61699995, #msg-59590951, #msg-48556414, and #msg-50473238 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now